← All companies
Celldex Therapeutics, Inc.
CLDX - CIK 0000744218
Market cap$2.30 B
Rank#1998
SEC filings1,268
The table below shows Celldex Therapeutics, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $28.87M | $28.36M | $34.81M | $29.43M | $39.14M | $43.84M |
| Short-term investments | $489.70M | $696.92M | $388.78M | $275.52M | $369.11M | $150.59M |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.